Magnetic resonance imaging was performed in children
Conditions
Interventions
Dexmedetomidine group:Sedative drug is dexmedetomidine
Sponsors
Kunming Children's Hospital
Eligibility
Sex/Gender
All
Age
1 Years to 10 Years
Inclusion criteria
Inclusion criteria: (1) outpatients or inpatients scheduled for MRI examination; (2) age 1-10 years old; (3) ASA grade I-II; (4) voluntarily participate in and sign the informed consent
Exclusion criteria
Exclusion criteria: (1) children with known hemodynamic or respiratory instability, airway abnormalities, cardiac defects or arrhythmias; (2) known to be allergic to remimazolam besylate and dexmedetomidine; (3) current use of dexmedetomidine or benzodiazepines for any treatment; (4) patients with cognitive impairment; (5) researchers considered that they were not suitable to participate in the clinical trial for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time of recovery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to onset;Heart rate;Blood pressure;Scan time;Whether to take remedial action;Whether flumazenil is needed;Adverse event rate; | — |
Countries
China
Contacts
Public ContactLi Guoyan
Kunming Children's Hospital
Outcome results
None listed